User's Manual

18. Supplemental information ........................................................... 59
18.1. Adverse events in the SafeR study ................................... 59
18.2. SafeR clinical study ............................................................ 61
19. Physical characteristics ............................................................... 64
19.1. Materials used ..................................................................... 64
20. Electrical characteristics ............................................................. 65
20.1. Table of delivered shock energy and voltage .................. 66
20.2. Battery ................................................................................. 66
20.3. Longevity ............................................................................. 67
21. Programmable parameters .......................................................... 69
21.1. Antibradycardia pacing ...................................................... 69
21.2. Ventricular tachyarrhythmia detection ............................. 74
21.3. Ventricular tachyarrhythmia therapies ............................. 76
21.4. Remote alerts and warnings .............................................. 80
22. Non programmable parameters .................................................. 82
23. Limited Warranty .......................................................................... 83
23.1. Article 1 : Terms of Limited warranty ............................... 83
23.2. Article 2 : Terms of replacement ....................................... 85
24. Patents ........................................................................................... 86
25. Explanation of symbols ............................................................... 87